BioMed entered the Cambridge, UK market in 2012, and since then has become a leading private owner and operator of life sciences office space, with a portfolio of nearly one million square feet in the city. Across its two major campuses in the region – BioMed@Babraham located on the Babraham Research Campus, and Granta Park – it supports over 30 life sciences companies, ranging from start-ups to established players such as AstraZeneca and Pfizer. This represents a formidable cluster of collaboration and innovation that employs more than 3,500 people.
James Seppala, Blackstone’s Head of Real Estate in Europe, and Tim Schoen, BioMed’s CEO, discuss the company’s portfolio in the UK today and why they’re excited about the market going forward.
*Article first published by 3BL CSRWire, 5th April, 2022